These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 28248408
1. Prognostic importance of central thrombus in hemodynamically stable patients with pulmonary embolism. Senturk A, Ozsu S, Duru S, Cakır E, Ulaslı SS, Demirdogen E, Kayhan S, Guzel A, Yakar F, Berk S. Cardiol J; 2017; 24(5):508-514. PubMed ID: 28248408 [Abstract] [Full Text] [Related]
2. Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome. Vedovati MC, Becattini C, Agnelli G, Kamphuisen PW, Masotti L, Pruszczyk P, Casazza F, Salvi A, Grifoni S, Carugati A, Konstantinides S, Schreuder M, Golebiowski M, Duranti M. Chest; 2012 Dec; 142(6):1417-1424. PubMed ID: 22628491 [Abstract] [Full Text] [Related]
3. Hypoxia as an independent predictor of adverse outcomes in pulmonary embolism. Subramanian M, Ramadurai S, Arthur P, Gopalan S. Asian Cardiovasc Thorac Ann; 2018 Jan; 26(1):38-43. PubMed ID: 29260572 [Abstract] [Full Text] [Related]
4. Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin. Rectenwald JE, Deatrick KB, Sukheepod P, Lynch EM, Moore AJ, Moaveni DM, Dewyer NA, Luke CE, Upchurch GR, Wakefield TW, Kunkel SL, Henke PK. J Vasc Surg; 2006 Apr; 43(4):800-8. PubMed ID: 16616240 [Abstract] [Full Text] [Related]
5. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group. Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK. Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025 [Abstract] [Full Text] [Related]
6. Comparison of LMWH versus UFH for hemorrhage and hospital mortality in the treatment of acute massive pulmonary thromboembolism after thrombolytic treatment : randomized controlled parallel group study. Ucar EY, Akgun M, Araz O, Tas H, Kerget B, Meral M, Kaynar H, Saglam L. Lung; 2015 Feb; 193(1):121-7. PubMed ID: 25351610 [Abstract] [Full Text] [Related]
7. Saddle pulmonary embolism: is it as bad as it looks? A community hospital experience. Sardi A, Gluskin J, Guttentag A, Kotler MN, Braitman LE, Lippmann M. Crit Care Med; 2011 Nov; 39(11):2413-8. PubMed ID: 21705903 [Abstract] [Full Text] [Related]
11. Prognostic role of a new risk index for the prediction of 30-day cardiovascular mortality in patients with acute pulmonary embolism: the Age-Mean Arterial Pressure Index (AMAPI). Zuin M, Rigatelli G, Picariello C, Carraro M, Zonzin P, Roncon L. Heart Vessels; 2017 Dec; 32(12):1478-1487. PubMed ID: 28642976 [Abstract] [Full Text] [Related]
12. Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism? Senturk A, Ucar EY, Berk S, Ozlu T, Altınsoy B, Dabak G, Cakır E, Kadıoglu EE, Sen HS, Ozsu S, TUPEG Study Investigators. Clin Appl Thromb Hemost; 2016 May; 22(4):395-9. PubMed ID: 25630985 [Abstract] [Full Text] [Related]
13. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K, Iversen S, Redecker M, Kienast J, Just H, Kasper W. Circulation; 1997 Aug 05; 96(3):882-8. PubMed ID: 9264496 [Abstract] [Full Text] [Related]
14. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin. Wang C, Zhai Z, Yang Y, Cheng Z, Ying K, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH, Davidson BL, China National Venous Thromboembolism (VTE) Study Group. Clin Respir J; 2016 Sep 05; 10(5):596-605. PubMed ID: 25619125 [Abstract] [Full Text] [Related]
15. Saddle vs Nonsaddle Pulmonary Embolism: Clinical Presentation, Hemodynamics, Management, and Outcomes. Alkinj B, Pannu BS, Apala DR, Kotecha A, Kashyap R, Iyer VN. Mayo Clin Proc; 2017 Oct 05; 92(10):1511-1518. PubMed ID: 28890217 [Abstract] [Full Text] [Related]
16. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, Kumbhani DJ, Mukherjee D, Jaff MR, Giri J. JAMA; 2014 Jun 18; 311(23):2414-21. PubMed ID: 24938564 [Abstract] [Full Text] [Related]
17. Role of clinical and pulmonary computed tomography angiographic parameters in the prediction of short- and long-term mortality in patients with pulmonary embolism. Etesamifard N, Shirani S, Jenab Y, Lotfi-Tokaldany M, Pourjafari M, Jalali A. Intern Emerg Med; 2016 Apr 18; 11(3):405-13. PubMed ID: 26712594 [Abstract] [Full Text] [Related]
18. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Kamphuisen PW, Agnelli G. Thromb Res; 2007 Apr 18; 119(3):265-74. PubMed ID: 16674999 [Abstract] [Full Text] [Related]
19. Suboptimal management of unfractionated heparin compared with low-molecular-weight heparin in the management of pulmonary embolism. Khor YH, Smith R, McDonald CF. Intern Med J; 2014 Apr 18; 44(4):339-44. PubMed ID: 24877250 [Abstract] [Full Text] [Related]
20. Risk-adjusted strategies in the prevention of early arterial thrombosis following lower extremity arterial reconstruction: a comparison of unfractionated versus low molecular weight heparin. Winkler MS, Larena-Avellaneda A, Diener H, Kölbel T, Debus ES. J Cardiovasc Surg (Torino); 2013 Feb 18; 54(1 Suppl 1):183-92. PubMed ID: 23443603 [Abstract] [Full Text] [Related] Page: [Next] [New Search]